To assess the contribution of epilepsy and diabetes to occupational injury.
Introduction
Epilepsy and diabetes mellitus are comparatively common chronic disorders in working-aged people, each with the potential to cause sudden temporary incapacity, either directly or as a complication of treatment. Consequently, restrictions have been placed on the employment of affected individuals in roles where incapacity could threaten their own safety or that of others (e.g. work at heights or driving trains, planes and ambulances) [1, 2] . However, it is possible that these restrictions are applied incompletely and are therefore insufficient, as currently implemented. On the other hand, some employers may apply unwarranted limitations on the placement of workers with epilepsy or diabetes [3, 4] . Unemployment rates are higher than average in people with epilepsy [5] and diabetes [6] , and there is concern that this might reflect unjustified discrimination.
Optimizing restrictions on employment is difficult because the evidence base on these diseases and occupational injury is limited. In a systematic review [7] , we found only four studies that estimated risks of workplace injury in relation to epilepsy [8] [9] [10] [11] and three in relation to diabetes [10, 12, 13] . Rates of injury were increased moderately, although the reports had several shortcomings, which meant that risks might have been overestimated.
An initial step in reducing the uncertainties is to assess the contributions of epilepsy and diabetes to workplace injury under the controls that currently apply. If risks are elevated despite current employment practices, then further action (e.g. tighter restrictions on job placement) may be indicated. If they are not, then further inquiries could focus on the experiences of working age people with epilepsy and diabetes and whether current restrictions on employment are all necessary. To address the first question, we conducted a case-control study of epilepsy, diabetes and workplace injury, based on the injury experience of a large sample of the British population over two decades.
Methods
The Clinical Practice Research Datalink (CPRD; formerly General Practice Research Database) is a research resource maintained by an agency of the Department of Health in England [14] under an 'approved uses' ethical licence. It records all consultations with a family doctor or hospital for people registered with ~590 participating general practices (~6% of the national population). Medical consultations, referrals and admissions are coded by the Read system, and drug prescriptions to categories in the British National Formulary (BNF). Data are checked for completeness and validity.
We undertook a nested case-control analysis within the cohort of patients registered on the CPRD between 1 January 1987 and 31 December 2009. Injury cases were defined as patients who had consulted their doctor or attended hospital with an occupational injury over this period. An algorithm was used to match the controls individually to cases of injury (five per case) by sex, year of birth, general practice and registration in the database at the time of the matched case's injury consultation (index date). Exposures of interest were counted only if prior to the index date.
The CPRD contains separate databases for consultations, treatment and clinical activities, linked by a unique identifier for each patient. Two of us independently searched the coding schemes for these files, looking for terms that might indicate a diagnosis of epilepsy. After discussion to resolve any differences, we distinguished 139 Read terms in the first database, which indicated a 'definite' diagnosis of epilepsy, and five terms that represented 'possible' epilepsy. In the second database, we found codes for 89 treatments specific to epilepsy, and 51 that were used not only for epilepsy but also for other indications. In the third database, we identified nine activities that all 'definitely' related to epilepsy (e.g. measured blood level of phenytoin; see Appendix for relevant codes, available as Supplementary data at Occupational Medicine Online). Patients were classed as having epilepsy if before the index date they had: (i) a Read code for 'definite' epilepsy or (ii) a Read code for 'possible' epilepsy corroborated by a treatment specific to epilepsy or by an activity 'definitely' indicating the disorder. When analysing risks by treatment at any time before and within the 12 months before the index date, we included medication that was not solely for epilepsy, provided the patient met our case definition for the disease.
Additionally, we searched for 196 Read terms relating to diabetes, 355 BNF formulary codes covering specific diabetes-related treatments and one code in the activity file for a relevant diabetic test (glycosylated haemoglobin [HbA 1c ]). We then used these to classify subjects as having diabetes or not (all subjects had a Read term for diabetes) and according to the severity of their disease and nature of their treatment (see Appendix for details, available as Supplementary data at Occupational Medicine Online). Patients with diabetes were subclassified according to whether they had (i) complications (i.e. eye involvement [e.g. proliferative retinopathy, cataract], neuropathy, foot ulceration, renal involvement or peripheral vascular disease) before the index date; (ii) hypoglycaemic treatments (i.e. insulin or an oral hypoglycaemic agent) ever and in the 12 months before the index date and (iii) poor control (i.e. a record of 'brittle' diabetes, diabetes with ketoacidosis, 'poor control', 'poor compliance' or 'unstable' disease) before the index date. Again, decisions about coding were taken by two of us independently, with differences resolved by discussion and blinded to case-control status.
Information was also abstracted on indices of high alcohol intake (e.g. diagnoses of alcoholic hepatitis, alcohol dependence, problem drinking or cirrhosis). With adjustment for high alcohol intake, associations of injury consultation with (i) epilepsy and its treatment and (ii) diabetes, its treatment and complications were assessed by conditional logistic regression and summarized by odds ratios (ORs) with 95% confidence intervals (CIs).
Results
We were supplied with an anonymized data set containing the full medical records of 1602 patients who had consulted their doctor or attended hospital with occupational injury over the period (479 diagnostic codes), and of 8010 patients with no such consultation. We excluded 1476 subjects who were aged 65 or older on the index date, 69 controls already matched to another case and 67 cases and their matched controls where the underlying injury proved to be non-accidental (e.g. assault at work). Where coded, injuries in the cases most often involved power tools or machinery (192 subjects), chemical or other burns (154 subjects) and poisonings or inhalation events (146 subjects). The commonest injuries involved sprains and soft tissue trauma (280 subjects), lacerations or open wounds (123 subjects), haematomas or crush injuries (78 subjects) and fractures (50 subjects). In all, 159 cases had visited hospital and 230 had received a sickness certificate.
Among the remaining 8000 subjects, 160 (2%) had documented epilepsy before their index date. The median duration of disease (from first record of diagnosis to the index date) was 14.7 years (interquartile range 5.6-22.2 years). Many patients had received more than one of the commonly prescribed treatments (Table 1) . Table 2 provides risk estimates for occupational injury in relation to epilepsy and epileptic treatment. Findings are presented for any diagnosis or treatment before the index date of injury consultation, for diagnosis at least 12 months before the index date and for treatments during the 12 months before the index date. (The second analysis was to exclude the possibility that the diagnosis of epilepsy might coincide with the injury rather than precede it and the third evaluated risks in relation to recent treatments that might impact on performance at work.) Risk overall was little different from that in people without epilepsy (adjusted OR 1.07, 95% CI 0.71-1.60) and no associations were found with diagnosis of epilepsy at least 12 months before the index date or with recent treatment for the disorder.
In all, 29 of the cases had epilepsy, including six with injuries that involved powered tools or machinery, seven with chemical poisonings or inhalation injuries and only one injured by a fall. One injury in a patient with epilepsy led to an amputation, but the others were mild (e.g. sprains and contusions). As far as can be judged from available descriptors, there was no indication that any workplace injury was a direct consequence of seizures and no individual had consulted about their epilepsy within the 100 days before their injury consultation. Two cases and six controls had previously suffered status epilepticus (adjusted OR versus never had epilepsy 1.61, 95% CI 0.32-7.96).
In total, 199 subjects (2.5%) had diabetes before the index date, including 86 treated with insulin and 75 prescribed an oral hypoglycaemic agent but never insulin. In all, 129 of these subjects had taken a blood sugar lowering agent in the previous 12 months. The overall median duration of illness, from first record of diagnosis to the index date, was 4.1 years (interquartile range 1.6-10.0 years). Eye involvement (usually diabetic retinopathy) was common (77 subjects), as was a clinical history of 'poor' control before the index date (52 subjects). In all, 117 diabetic subjects (59%) had an HbA 1c test within the 12 months before the index date, and in 84 of these, it was ≥7% (53 mmol/mol), a cut-point often taken to indicate suboptimal control. 
Discussion
These results provide broad reassurance. No statistically significant elevation of risk was found in any of the analyses conducted, including those focusing on more severe epilepsy, diabetic complications, poorer diabetic control and treatments that might impair consciousness, awareness or concentration. Moreover, the upper 95% confident limits of risk estimates indicate that major effects of epilepsy and diabetes are unlikely to have been missed simply by chance. As a tool for this type of research, the CPRD has several strengths and a few limitations. The database allowed us to identify a large sample of patients with occupational injuries, and of matched controls, from a sampling frame likely to be generally representative of the total population (almost everyone in Britain registers with a family doctor for services that are free at the point of delivery). Also, the CPRD has been reported to have a high degree of completeness (>97%) and validity for several previously assessed measures [15] . On the other hand, the database records injuries only if they present to medical care and not self-treated injuries or near miss events. Also the coding system is complex, meaning that we may not have identified every case of injury within the system, and a comparison with the Reporting of Injuries, Diseases and Dangerous Occurrences statistics over the study period suggests a substantial level of under-ascertainment of cases. The most likely explanation is that we focused only on cases that could be ascribed with confidence to occupation, whereas the coding of many injuries did not allow this determination. However, omissions would probably be non-differential in relation to occurrence of diabetes or epilepsy. Additionally, patients' occupations are not consistently recorded, meaning that while cases (by definition) will have been employed, we could not restrict the selection of controls to employed patients. Also, cases may have been drawn more from manual occupations than controls. In principle, bias could arise if controls over-represented the prevalence of illnesses or treatments that prevented work (leading to underestimation of risks), or if such illnesses and treatments were more common in manual jobs (leading to overestimation of risks). Elsewhere, however, we have shown that the net effect of these opposing biases is likely to be small in practice [16] .
Earlier reports on epilepsy and workplace injury have indicated greater risks than we found, as have studies in workers with diabetes. However, the associations described could have arisen by chance or through bias, and as such are not incompatible with our findings. Two American studies of epilepsy [9, 10] were based on simultaneous self-report of exposure (history of fitting) and of outcome (injury). Risks could, therefore, have been overestimated because of reporting bias or reverse causation. The former might occur if those with epilepsy tended on average to have better recall of injuries (e.g. be more motivated or health aware) or if interviewers, knowing a person's diagnosis, Read codes for 'brittle diabetes', ketoacidosis/ketoacidotic coma, 'poor control', 'poor compliance', and 'unstable diabetes'.
probed more thoroughly when asking individuals with epilepsy about their injury record. Furthermore, both studies were subject to substantial statistical uncertainty (evidenced by wide CIs for risk estimates), as was a third investigation [8] . A cohort study by Cornaggia et al. [11] recruited over 600 adults with epilepsy from specialist centres across eight European countries and found that risks of occupational injury were elevated 2.5-fold (P < 0.05). Controls, however, came from a volunteer group of relatives, friends or workmates, rather than a representative sample of the general population, and the sample analysed included unemployed people, housewives, pensioners and students in education, half of whom could not be at risk of a workplace injury. Injury events, although prospectively recorded over follow-up in personal diaries, were self-reported. The 22 occupational injuries in patients with epilepsy and nine in controls essentially comprised contusions and haematomas, minor burns, wounds and abrasions; only two were considered to be seizure-related, both being minor. In the National Health Interview Survey, a cross-sectional multistage probability survey of US households, odds of occupational injury in the past year were raised 1.47-fold among workers with diabetes, although findings were not statistically significant despite a sample size of 76 000 [10] . In a US casecontrol study dispensing of hypoglycaemic medication in the previous 30 days was associated with an OR for hospital attendance with work-related injury of 1.3-1.4 (P > 0.05) [12] . In a case-control study of Canadian farmers, hospital attendance with an agriculture-related injury was inconsistently related to diabetic medication [13] . Finally, an analysis of recordable injuries and injuries requiring first aid in the medical claims database of a large multinational manufacturer found that risk of injury was increased, but only modestly (hazard ratio 1.17, P < 0.05) [17] . As posited in our introduction, risks of workplace injury in people with epilepsy and diabetes are liable to be lowered by their selective exclusion from some types of employment. For example, the somewhat reduced risks associated with diabetic eye involvement and poor diabetic control could be explained by people with the worst health being differentially selected out of hazardous work. More generally, the absence of elevated risks may reflect selection. For this reason, we cannot rule out effects of diabetes and epilepsy on risk of occupational injury. It seems safe to conclude, however, that in general, current employment practice in Britain is not placing workers with these diseases at undue risk of injury. Thus, there is no pressing case for tighter restrictions or pre-placement screening than currently apply. The possibility remains that important numbers of people with epilepsy and diabetes are being excluded from employment because of restrictions that are unnecessary. A next step in investigating this would be to establish the experiences of representative samples of people of working age with epilepsy and diabetes in relation to job-seeking and employment.
Key points
• In this case-control study, based on a population sample and two decades of data, no evidence was found that diabetes and epilepsy contribute importantly to workplace injury.
• There appears to be no pressing case for tighter restrictions or pre-placement screening than currently apply.
• Future research could focus on whether important numbers of people with epilepsy and diabetes are being excluded from employment because of restrictions that are unnecessary.
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The raincoat sign
She was wearing the most fluorescent raincoat I think I have ever seen but I already knew from our previous meeting that the consultation was likely to be interesting. She had initially been referred by her manager, who was concerned by her behaviour, and at that first appointment she had announced her presence to all and sundry by demanding to know very loudly who I was when I invited her to come through from the waiting room. At the end of that consultation we had fortunately agreed that she was unfit to work and I had written to the general practitioner expressing my concerns about her mental state. Those prior concerns were confirmed at the second consultation where, despite informing me after 5 min that she didn't wish to proceed, I was still trying to terminate the consultation an hour later. She grabbed the copy of my letter to the GP, annotated it with what can only be described as violent flourishes of a pencil and then refused to let me have it back before ripping it up in my face. She spontaneously reassured me that she was unlikely to become physically aggressive; I wasn't convinced. How could I accuse her of delusional infestational paranoia she demanded? I couldn't because it wasn't a term I had used or even heard of. When she finally stormed out of the consultation room it was only to continue shouting and gesticulating in the waiting area. She finally announced she was going for a walk despite an on-going downpour of monsoon proportions and the lack of any convincing waterproofing protection apart from her very short but bright raincoat. There was relief mixed with apprehension for the whole department when she returned half an hour later and finally drove away. I rang the GP to further express my concerns and then her manager to suggest her professional body was contacted. Some patients announce themselves by their accessories: the tinted glasses, the cervical collar, the crutches, the walking stick. Some, like the collar, seem to have gone out of fashion, discredited by lack of evidence. Others are acceptable; a randomized control trial of walking sticks in osteoarthritis of the knee has shown them to be of significant benefit in pain reduction and improved mobility. But what about the delusional woman and her fluorescent raincoat? Would she normally wear something like that? She wouldn't normally behave like that so perhaps it is a clinical sign? The detection of delusion in the occupational health clinic is rarely straightforward; some patients present on-going and long-term conundrums, tolerated by their communities, workplaces and general practitioners, often for decades as it is easier to accept them as just strange rather than upsetting the apple cart. They resist medication unless there is a true crisis and then stop taking it once better so the cycle repeats. The last I heard my delusional lady had returned to normal but not to work as she refused to see occupational health.
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